Publication | Closed Access

6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine

VaccinationToll-like ReceptorsCross-protectionToll-like Receptor 7Vaccine DevelopmentAllergySelf-adjuvanting Peptide VaccineVaccine TargetImmunologyAutoimmunityVaccine DesignImmunotherapyMedicineVaccine ResearchAgonist Amino Acid